Clinical Trial Details
EORTC-62061
Back to Clinical Trials Database
Randomized phase II study of brostallicin (PNU-166196A) versus doxorubicin as first line chemotherapy in patients with advanced or metastatic soft tissue sarcoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 25-Oct-2006 Date Step1 close: 17-Sep-2008 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | All Groups: 108 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00410462 |
| NCT number | NCT00410462 |
| EudraCT | 2006-001861-40 |
